Showing results (81-90 of 536) with videos related to
Sort By:
Pageof 54
European Urology|April 22, 2008
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), RotterdamClaartje Gosselaar, Monique J Roobol, Stijn Roemeling, et al.Journal of Applied Crystallography|August 26, 2015
BINoculars: data reduction and analysis software for two-dimensional detectors in surface X-ray diffractionSander Roobol, Willem Onderwaater, Jakub Drnec, et al.Expert Review of Anticancer Therapy|July 22, 2010
Should prostate-specific antigen screening be offered to asymptomatic men?Heidi A van Vugt, Chris H Bangma, Monique J RoobolCell Stress & Chaperones|December 17, 2002
Eukaryotic chaperonin containing T-complex polypeptide 1 interacts with filamentous actin and reduces the initial rate of actin polymerization in vitroJulie Grantham, Lloyd W Ruddock, Anne Roobol, et al.BJU International|September 25, 2012
Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) RotterdamStacy Loeb, Xiaoye Zhu, Fritz H Schroder, et al.American Journal of Clinical and Experimental Urology|January 22, 2015
Active surveillance for prostate cancer: a legal perspectiveLionne Df Venderbos, Monique J Roobol, August Nl de HooghCell Motility and the Cytoskeleton|January 1, 1987
Patterns of tubulin isotype synthesis and usage during mitotic spindle morphogenesis in PhysarumE C Paul, A Roobol, K E Foster, et al.Urologic Oncology|September 6, 2021
Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteriaLionne Df Venderbos, Henk Luiting, Renée Hogenhout, et al.Urology|May 12, 2004
No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam)M J Roobol, I W van der Cruijsen, F H SchröderEuropean Urology|March 21, 2008
Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)Tineke Wolters, Monique J Roobol, Chris H Bangma, et al.Pageof 54